Enhancing "Patient-Reported Outcomes" through Wearable Technology and the Rise of "Home-Based" Clinical Assessments within the Duchenne Muscular Dystrophy Treatment Sector for 2026
In early 2026, the way we measure "Success" in Duchenne treatment is moving out of the hospital and into the home. Traditional tests like the "6-Minute Walk Test" (6MWT) are being supplemented—and in some cases replaced—by "Wearable Stride Monitors." These devices, worn on the ankle or wrist, provide a "Continuous Stream" of data on how a child moves in their natural environment...
0 Comments 0 Shares 273 Views 0 Reviews
Sponsored

High CPM Rates (Especially For Tier 1 Countries)

🚀 Boost your earnings with PopAds.net – #1 pop-under ad network with fast payouts and high rates.